BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:16 AM | Browse: 53 | Download: 73
 |
Received |
|
2024-08-11 14:45 |
 |
Peer-Review Started |
|
2024-08-11 14:45 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-10-20 11:03 |
 |
Revised |
|
2024-11-03 05:48 |
 |
Second Decision |
|
2024-12-13 02:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-12-13 06:25 |
 |
Articles in Press |
|
2024-12-13 06:25 |
 |
Publication Fee Transferred |
|
2024-11-09 01:21 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-01-22 03:43 |
 |
Publish the Manuscript Online |
|
2025-02-14 10:33 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Case Report |
Article Title |
Penile metastasis from colon cancer with BRAFV600E mutation treated with BRAF/MEK-targeted therapy plus cetuximab: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jun-Chen Wu, Hua-Xi Cheng, Qiu-Sheng Lan, He-Yang Xu, Yu-Jie Zeng, Wei Lai and Zhong-Hua Chu |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
81871981 |
Natural Science Foundation of Guangdong Province |
2022A1515012348 and 2023A1515010457 |
|
Corresponding Author |
Zhong-Hua Chu, MD, PhD, Professor, Department of Gastrointestinal Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107 Yan Jiang West Road, Guangzhou 510120, Guangdong Province, China. chuzhh@mail.sysu.edu.cn |
Key Words |
Colon cancer; Penile metastasis; BRAFV600E mutation; Targeted therapy; Case report |
Core Tip |
Despite the increasing incidence and prevalence of colorectal cancer among malignant tumors, penile metastasis originating from colorectal cancer remains a rare occurrence. The precise mechanism underlying penile metastasis of colorectal cancer remains elusive, and its specific treatment remains a subject of controversy, particularly in patients with BRAFV600E mutation, which often signifies an unfavorable prognosis. In our case, the treatment of BRAF/MEK-targeted therapy (dabrafenib and trametinib) plus cetuximab demonstrated promising outcomes, leading to tumor regression and prolonged survival, thereby offering valuable insights for the management of analogous cases. |
Publish Date |
2025-02-14 10:33 |
Citation |
<p>Wu JC, Cheng HX, Lan QS, Xu HY, Zeng YJ, Lai W, Chu ZH. Penile metastasis from colon cancer with BRAFV600E mutation treated with BRAF/MEK-targeted therapy plus cetuximab: A case report. <i>World J Gastrointest Oncol</i> 2025; 17(3): 100152</p> |
URL |
https://www.wjgnet.com/1948-5204/full/v17/i3/100152.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v17.i3.100152 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345